Literature DB >> 30737289

Tumor-suppressive signaling in the uterus.

Qinglei Li1.   

Abstract

Mesh：

Substances：

Year:  2019        PMID： 30737289      PMCID： PMC6397540          DOI： 10.1073/pnas.1821606116

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  19 in total

Review 1.  TGFbeta signaling in growth control, cancer, and heritable disorders.

Authors:  J Massagué; S W Blain; R S Lo
Journal:  Cell       Date:  2000-10-13       Impact factor: 41.582

Review 2.  Estrogen and the endometrium: lessons learned from gene expression profiling in rodents and human.

Authors:  P G Groothuis; H H N M Dassen; A Romano; C Punyadeera
Journal:  Hum Reprod Update       Date:  2007 Jul-Aug       Impact factor: 15.610

3.  Redundant roles of SMAD2 and SMAD3 in ovarian granulosa cells in vivo.

Authors:  Qinglei Li; Stephanie A Pangas; Carolina J Jorgez; Jonathan M Graff; Michael Weinstein; Martin M Matzuk
Journal:  Mol Cell Biol       Date:  2008-09-22       Impact factor: 4.272

4.  Aberrant expression and mutations of TGF-beta receptor type II gene in endometrial cancer.

Authors:  Junko Sakaguchi; Satoru Kyo; Taro Kanaya; Yoshiko Maida; Manabu Hashimoto; Mitsuhiro Nakamura; Kiyofumi Yamada; Masaki Inoue
Journal:  Gynecol Oncol       Date:  2005-09       Impact factor: 5.482

Review 5.  Signaling by members of the TGF-beta family in vascular morphogenesis and disease.

Authors:  Evangelia Pardali; Marie-José Goumans; Peter ten Dijke
Journal:  Trends Cell Biol       Date:  2010-07-23       Impact factor: 20.808

6.  Transforming growth factor beta signaling is disabled early in human endometrial carcinogenesis concomitant with loss of growth inhibition.

Authors:  Trilok V Parekh; Patricia Gama; Xie Wen; Rita Demopoulos; John S Munger; Maria-Luisa Carcangiu; Michael Reiss; Leslie I Gold
Journal:  Cancer Res       Date:  2002-05-15       Impact factor: 12.701

7.  Expression and clinical significance of the transforming growth factor-β signalling pathway in endometrial cancer.

Authors:  Joshua Kesterson; Dan Wang; Paulette Mhawech-Fauceglia; Stacey Akers; Nefertiti Chianti DuPont; Kimberly Clark; Shashikant Lele; Song Liu
Journal:  Histopathology       Date:  2011-07       Impact factor: 5.087

Review 8.  Role of transforming growth factor-beta superfamily signaling pathways in human disease.

Authors:  Kelly J Gordon; Gerard C Blobe
Journal:  Biochim Biophys Acta       Date:  2008-02-11

9.  Transforming growth factor β receptor type 1 is essential for female reproductive tract integrity and function.

Authors:  Qinglei Li; Julio E Agno; Mark A Edson; Ankur K Nagaraja; Takashi Nagashima; Martin M Matzuk
Journal:  PLoS Genet       Date:  2011-10-20       Impact factor: 5.917

10.  Integrated genomic characterization of endometrial carcinoma.

Authors:  Cyriac Kandoth; Nikolaus Schultz; Andrew D Cherniack; Rehan Akbani; Yuexin Liu; Hui Shen; A Gordon Robertson; Itai Pashtan; Ronglai Shen; Christopher C Benz; Christina Yau; Peter W Laird; Li Ding; Wei Zhang; Gordon B Mills; Raju Kucherlapati; Elaine R Mardis; Douglas A Levine
Journal:  Nature       Date:  2013-05-02       Impact factor: 49.962
View more
  3 in total

1.  Estrogen receptor α (ERα)-binding super-enhancers drive key mediators that control uterine estrogen responses in mice.

Authors:  Sylvia C Hewitt; Sara A Grimm; San-Pin Wu; Francesco J DeMayo; Kenneth S Korach
Journal:  J Biol Chem       Date:  2020-04-30       Impact factor: 5.157

2.  Reply to Liu et al.: ALK5-mediated tumor suppressor signaling through SMAD2 and SMAD3 in the uterus.

Authors:  Diana Monsivais; Maya Kriseman; Chad J Creighton; Martin M Matzuk
Journal:  Proc Natl Acad Sci U S A       Date:  2019-05-07       Impact factor: 11.205

3.  Functional similarity between TGF-beta type 2 and type 1 receptors in the female reproductive tract.

Authors:  Nan Ni; Xin Fang; Qinglei Li
Journal:  Sci Rep       Date:  2021-04-29       Impact factor: 4.379
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.